Michael A. Nukkala

Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent

Qun Li, Keith W. Woods, Akiyo Claiborne et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 124 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models

Bruce G. Szczepankiewicz, Gang Liu, Hwan-Soo Jae et al. · Journal of Medicinal Chemistry · 2001 · 66 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Novel sulfonate analogues of combretastatin A-4

Stephen L. Gwaltney, Hovis Imade, Kenneth J. Barr et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivative.

Stephen K. Tahir, Michael A. Nukkala, Nicolette A. Zielinski Mozny et al. · PubMed · 2003 · 42 citations

Medicine, Oncology, Pharmacology +16

Efficacies of ABT-773, a New Ketolide, against Experimental Bacterial Infections

Michael J. Mitten, Jonathan A. Meulbroek, Michael A. Nukkala et al. · Antimicrobial Agents and Chemotherapy · 2001 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16